Nama's AI scorecard currently rates Labcorp Hold (5.6 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is LH's P/E ratio?

Labcorp trades at a trailing price-to-earnings ratio of 20.3.

When does LH report earnings?

Labcorp's next scheduled report is on Feb 23, 2027. Analysts expect EPS of $4.51.

What is the LH price target?

The median analyst price target from 16 analysts is $384.00, with a range of $330.00 – $420.00.

Is LH Shariah compliant?

Nama's AAOIFI-style screen reads Labcorp as Not Shariah Compliant. At least one of the three ratios or the industry test failed.

Does LH pay a dividend?

Yes — Labcorp's dividend yield is 0.8%.

Nama Insights

Labcorp (LH)

Healthcare · Diagnostics Research · NYSE

S&P 500

Labcorp (LH) is a Healthcare company in the Diagnostics Research industry. It has a market capitalization of $29.77B, a trailing price-to-earnings ratio of 20.3 and a free-cash-flow yield of 3.9%. Over the most recent reported fiscal year, revenue grew 7.2% and free cash flow per share grew 10.8%. Nama's AI scorecard rates it Hold, 5.6 out of 10. On 12-month momentum it ranks in the rising band of its market.

AI scorecard

Hold · 5.6/10

The sections balance. As of Nov 7, 2026.

Momentum

Rising · +26.5% over 12 months ex. last

Second-best fifth of its market on the past year's move.

Shariah screen

Not Shariah Compliant

At least one of the three ratios or the industry test failed.

Off its high

-1.8%

How far the last close sits under the highest price of the past five years.

Market cap	$29.77B
Trailing P/E	20.3
Price / book	3.5
Price / sales	2.0
FCF yield	3.9%
Dividend yield	0.8%
Gross margin	28.9%
Operating margin	11.3%
Net margin	7.0%
Revenue growth (YoY)	+7.2%
Revenue growth (3-yr annual)	+5.5%
EPS growth (YoY)	+12.8%
FCF/share growth (YoY)	+10.8%
Beta	0.8
Exchange	NYSE
Sector	Healthcare
Industry	Diagnostics Research

LH earnings

Next report: Feb 23, 2027 (Q4 2026, EPS estimate $4.51). Beat the EPS estimate in 4 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Oct 28, 2026	$4.78	$4.64	+3.0%	$3.81B
Q2 2026	Jul 30, 2026	$4.99	$4.77	+4.6%	$3.73B
Q1 2026	Apr 30, 2026	$4.25	$4.12	+3.2%	$3.54B
Q4 2025	Feb 17, 2026	$4.07	$3.94	+3.3%	$3.52B

LH analyst price target

Median target $384.00 from 16 analysts, ranging $330.00 – $420.00.

Diagnostics Research peers

Ticker	Company	Market cap	P/E
TMO	Thermo Fisher Scientific	$257.42B	28.1
DHR	Danaher	$161.86B	27.6
IDXX	IDEXX Laboratories	$53.26B	45.6
A	Agilent Technologies	$49.28B	28.8
WAT	Waters	$44.93B	31.8
IQV	IQVIA	$44.80B	21.2
NTRA	Natera	$44.78B	—
MTD	Mettler-Toledo International	$34.51B	37.2

Explore live LH data on Nama Insights →

Recent Congressional trades

Labcorp trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
April McClain Delaney	House	Sell	$100,001 - $250,000	Sep 9, 2026
April McClain Delaney	House	Sell	$1,001 - $15,000	Sep 9, 2026
April McClain Delaney	House	Sell	$1,001 - $15,000	Sep 9, 2026
April McClain Delaney	House	Sell	$1,001 - $15,000	Sep 9, 2026
Alan Armstrong	Senate	Buy	$1,001 - $15,000	Jul 21, 2026
April McClain Delaney	House	Buy	$1,001 - $15,000	Mar 10, 2026
April McClain Delaney	House	Buy	$1,001 - $15,000	Mar 10, 2026
April McClain Delaney	House	Buy	$1,001 - $15,000	Feb 2, 2026
April McClain Delaney	House	Buy	$1,001 - $15,000	Dec 8, 2025
April McClain Delaney	House	Buy	$1,001 - $15,000	Nov 4, 2025
April McClain Delaney	House	Buy	$1,001 - $15,000	Nov 4, 2025
Rob Bresnahan	House	Buy	$1,001 - $15,000	May 31, 2025

LH FAQ

Is LH a buy?: Nama's AI scorecard currently rates Labcorp Hold (5.6 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is LH's P/E ratio?: Labcorp trades at a trailing price-to-earnings ratio of 20.3.
When does LH report earnings?: Labcorp's next scheduled report is on Feb 23, 2027. Analysts expect EPS of $4.51.
What is the LH price target?: The median analyst price target from 16 analysts is $384.00, with a range of $330.00 – $420.00.
Is LH Shariah compliant?: Nama's AAOIFI-style screen reads Labcorp as Not Shariah Compliant. At least one of the three ratios or the industry test failed.
Does LH pay a dividend?: Yes — Labcorp's dividend yield is 0.8%.